Supernus advertising spend, FY2025

Supernus (SUPN) reported $124M of advertising expense for the fiscal year ended Dec 31, 2025. That is 10.0% of revenue of $1.2B. Up 82.4% from FY2024. Formerly Indivior Pharmaceuticals and Indivior.

Ad spend, FY2025
$124M
year ended Dec 31, 2025
Change vs prior year
+82.4%
vs FY2024
Share of revenue
10.0%
of $1.2B revenue
Rank by ad spend
#304
of 458 companies

Key facts

  • Ad spend is 2.4x its FY2022 level ($52M), faster than revenue (1.4x).
  • FY2025 is the highest year on file, going back to FY2022.
  • Largest increase +82.4% in FY2025.
  • Ad spend has risen 3 years in a row.
  • Supernus spends more on advertising than 34% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is 2.2x the median of 4.5%.

Ad spend by fiscal year

$0 $50M $100M $150M FY2022 (ended 2022-12-31): $52M 2022 FY2023 (ended 2023-12-31): $53M 2023 FY2024 (ended 2024-12-31): $68M 2024 FY2025 (ended 2025-12-31): $124M 2025 $124M

Ad spend as % of revenue

0% 5% 10% 15% FY2022 (ended 2022-12-31): 5.8% 2022 FY2023 (ended 2023-12-31): 4.8% 2023 FY2024 (ended 2024-12-31): 5.7% 2024 FY2025 (ended 2025-12-31): 10.0% 2025 10.0%

Ad spend in context, FY2025

Advertising was 19.6% of selling, general and administrative expense. Advertising was 1.3x research and development spending. Advertising equalled 47.3% of operating income.

Advertising $124M AdvertisingExpense
Selling, general and administrative $634M ad spend = 19.6%
Research and development $97M ad spend = 1.3x R&D
Operating income $262M ad spend = 47.3%
Net income $210M

Same fiscal year and filing as the ad spend. Selling and marketing and SG&A usually include advertising.

History

Download CSV
Fiscal year Period end Ad spend YoY Revenue Ad / revenue Tag Filing
FY2025 Dec 31, 2025 $124M +82.4% $1.2B 10.0% AdvertisingExpense 10-K Feb 26, 2026
FY2024 Dec 31, 2024 $68M +28.3% $1.2B 5.7% AdvertisingExpense 10-K Feb 26, 2026
FY2023 Dec 31, 2023 $53M +1.9% $1.1B 4.8% AdvertisingExpense 10-K Feb 26, 2026
FY2022 Dec 31, 2022 $52M n/a $901M 5.8% AdvertisingExpense 10-K Mar 3, 2025

Ad spend, revenue and the ratio come from the linked filing. YoY compares each year with the fiscal year directly before it, under the same tag. A gap, a change of tag or a change of fiscal year end leaves it blank.

What the figure is

Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).

Compared with similar spenders

The 6 companies closest to Supernus in latest-year ad spend.

Rank Company Ad spend Ad / revenue YoY Fiscal year
300 Paycom Software $126M 6.1% +45.4% FY2025
301 ZipRecruiter $125M 27.9% +27.7% FY2025
302 CNH Industrial $125M 0.7% +4.2% FY2025
303 Six Flags Entertainment $124M 4.0% +20.5% FY2025
304 Supernus $124M 10.0% +82.4% FY2025
305 Generac $123M 2.9% +5.7% FY2025
306 Lyft $123M 1.9% -10.2% FY2025

Full ranking of 458 companies · Biggest increases #17 · More on ads than R&D #82

Questions

How much does Supernus spend on advertising?

Supernus spent $124M on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Feb 26, 2026.

What percentage of revenue does Supernus spend on advertising?

10.0% of revenue in fiscal 2025 ($124M against $1.2B). The median across the 458 companies tracked is 4.5%.

Is Supernus spending more on advertising?

Yes. Ad spend rose 82.4% in fiscal 2025 from fiscal 2024. It has risen 3 years in a row.

How does Supernus rank by advertising spend?

#304 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.

Does Supernus spend more on advertising than on R&D?

Yes. In fiscal 2025 it spent $124M on advertising and $97M on research and development.

What does Supernus's advertising figure include?

Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).

Company and source

Filing
10-K for FY2025, filed Feb 26, 2026
Accession number
0001628280-26-012237
Company
Supernus, Inc., CIK 1625297, SIC 2834 (Pharmaceutical Preparations)
Former names
Indivior Pharmaceuticals, Indivior
Headquarters
Rockville, MD
Incorporated in
DE
Fiscal year ends
December 31
Listed on
Nasdaq, Nasdaq
SEC filer status
Large accelerated filer
Data
SEC EDGAR XBRL company facts, retrieved Nov 18, 2026. Methodology.
Cite
Supernus advertising spend, FY2022-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Feb 26, 2026), retrieved Nov 18, 2026. https://io.trudov.com/company/supernus/advertising-spend/
Download
CSV, all years · CSV, all 458 companies